Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

Imaging Studies IV: Magnetic Resonance Imaging

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A case of metastatic primary cardiac angiosarcoma.

The journal of the Royal College of Physicians of Edinburgh·2021

Same author

Creating a model to predict time intervals from induction of labor to induction of anesthesia and delivery to coordinate workload.

International journal of obstetric anesthesia·2021

Same author

Efficient production of a high-performance dispersion strengthened, multi-principal element alloy.

Scientific reports·2020

Same author

Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event.

The British journal of dermatology·2019

Same author

Lipid composition of the pecan weevil,Curculio caryae (Horn).

Lipids·2016

Same author

Identification of feeding stimulants for boll weevils from cotton buds and anthers.

Journal of chemical ecology·2013

Same journal

Machine learning models using 18F-FDG PET/CT radiomics for RAS mutation prediction and prognostic stratification in colorectal cancer.

The British journal of radiology·2026

Same journal

Predictors of Relapse in Oligometastatic Prostate Patients Receiving Stereotactic Ablative Radiotherapy.

The British journal of radiology·2026

Same journal

An Evaluation of Radiotherapy and Response in the Management of Perivascular Epithelioid Cell Tumors.

The British journal of radiology·2026

Same journal

Ensuring radiology reporting quality across a national lung cancer screening programme.

The British journal of radiology·2026

Same journal

Utility of High-Resolution Semiconductor Positron Emission Tomography/Computed Tomography in the Assessment of Breast Cancer Extent: Comparison with Magnetic Resonance Imaging.

The British journal of radiology·2026

Same journal

Airway Imaging Practices in Primary Ciliary Dyskinesia: A Global Survey to Guide Standardized Guidelines.

The British journal of radiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Dynamic contrast-enhanced MRI for prostate cancer localization.

A S N Jackson¹, S A Reinsberg, S A Sohaib

¹Academic Department of Radiotherapy and Oncology, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK. Andrew.Jackson@manchester.ac.uk

The British Journal of Radiology

|January 27, 2009

Summary

This summary is machine-generated.

Dynamic contrast-enhanced MRI (DCE-MRI) shows promise for improving prostate cancer radiotherapy. This technique better localizes tumors than conventional MRI, potentially enabling dose escalation with reduced toxicity.

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Related Experiment Videos

Last Updated: Jun 26, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Area of Science:

Oncology
Radiology
Medical Imaging

Background:

Radiotherapy dose escalation enhances prostate cancer tumor control but increases toxicity.
Focal tumor boosting may permit dose escalation with acceptable toxicity.
Intensity-modulated radiotherapy requires accurate tumor visualization, which is currently limited.

Purpose of the Study:

To evaluate the accuracy of dynamic contrast-enhanced MRI (DCE-MRI) for prostate cancer detection and localization.
To compare the efficacy of DCE-MRI with T2-weighted (T2W) MRI in identifying tumor locations prior to treatment.

Main Methods:

18 prostate cancer patients underwent T2W and DCE-MRI before prostatectomy.
Prostatectomy specimens were meticulously sectioned for precise correlation with imaging.
Pixel-by-pixel analysis compared quantitative DCE-MRI parameters (Ktrans, ve, kep) and radiologist interpretations with histopathology.

Main Results:

Quantitative DCE-MRI parameters (Ktrans, ve, kep) showed significant differences between benign and cancerous prostate tissue.
DCE-MRI demonstrated higher sensitivity (50% vs. 21%) than T2W images for tumor localization.
DCE-MRI maintained high specificity (85% vs. 81%) compared to T2W images.

Conclusions:

DCE-MRI offers superior sensitivity for prostate cancer tumor localization compared to T2W imaging.
The high sensitivity and specificity of DCE-MRI support its use in guiding radiotherapy boosts.
This technique may facilitate dose-escalated focal radiotherapy, improving treatment outcomes while managing toxicity.